Business Wire08.29.16
MS Health Holdings Inc. and Quintiles Transnational Holdings Inc. today announced key senior management roles in the future Quintiles IMS corporate leadership team, subject to the completion of the merger.
Senior functional leaders reporting to chairman and CEO Ari Bousbib will include Michael McDonnell, executive vice president and chief financial officer; James Erlinger, executive vice president and general counsel; and Trudy Stein, executive vice president and chief human resources officer.
Global business leaders reporting to Bousbib will include, for the clinical research business, Tom Pike, vice chairman and president, Research & Development Solutions; and for the commercial business, Kevin Knightly, president, Information and Technology Solutions; José Luis Fernández, president, Global Services; Jon Resnick, president, Real-World Insights; and Scott Evangelista, president, Contract Sales Organization.
“I am proud to be part of a leadership team with deep industry knowledge, a proven track record of success and a commitment to transforming healthcare for the better,” said Bousbib. “That commitment extends across the 50,000 professionals who will soon become part of one global team. Together, we are making excellent progress on our integration planning and are confident that we will be ready for a strong start on day one of the merger.”
IMS Health is a global information and technology services company providing clients in the healthcare industry with end-to-end solutions to measure and improve their performance. Its 7,000 services experts connect configurable SaaS applications to more than 15 petabytes of complex healthcare data in the IMS One cloud platform, delivering unique insights into diseases, treatments, costs and outcomes. The company’s 15,000 employees blend global consistency and local market knowledge across 100 countries to help clients run their operations more efficiently. Customers include pharmaceutical, consumer health and medical device manufacturers and distributors, providers, payers, government agencies, policymakers, researchers and the financial community.
IMS Health uses anonymous healthcare data to deliver critical, real-world disease and treatment insights. These insights help biotech and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders to identify unmet treatment needs and understand the effectiveness and value of pharmaceutical products in improving overall health outcomes.
From advisory through operations, Quintiles is the world’s largest provider of product development and integrated healthcare services, including commercial and observational solutions. Conducting operations in approximately 100 countries, Quintiles is a member of the Fortune 500 and has been named to Fortune’s list of the “World’s Most Admired Companies.”
Senior functional leaders reporting to chairman and CEO Ari Bousbib will include Michael McDonnell, executive vice president and chief financial officer; James Erlinger, executive vice president and general counsel; and Trudy Stein, executive vice president and chief human resources officer.
Global business leaders reporting to Bousbib will include, for the clinical research business, Tom Pike, vice chairman and president, Research & Development Solutions; and for the commercial business, Kevin Knightly, president, Information and Technology Solutions; José Luis Fernández, president, Global Services; Jon Resnick, president, Real-World Insights; and Scott Evangelista, president, Contract Sales Organization.
“I am proud to be part of a leadership team with deep industry knowledge, a proven track record of success and a commitment to transforming healthcare for the better,” said Bousbib. “That commitment extends across the 50,000 professionals who will soon become part of one global team. Together, we are making excellent progress on our integration planning and are confident that we will be ready for a strong start on day one of the merger.”
IMS Health is a global information and technology services company providing clients in the healthcare industry with end-to-end solutions to measure and improve their performance. Its 7,000 services experts connect configurable SaaS applications to more than 15 petabytes of complex healthcare data in the IMS One cloud platform, delivering unique insights into diseases, treatments, costs and outcomes. The company’s 15,000 employees blend global consistency and local market knowledge across 100 countries to help clients run their operations more efficiently. Customers include pharmaceutical, consumer health and medical device manufacturers and distributors, providers, payers, government agencies, policymakers, researchers and the financial community.
IMS Health uses anonymous healthcare data to deliver critical, real-world disease and treatment insights. These insights help biotech and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders to identify unmet treatment needs and understand the effectiveness and value of pharmaceutical products in improving overall health outcomes.
From advisory through operations, Quintiles is the world’s largest provider of product development and integrated healthcare services, including commercial and observational solutions. Conducting operations in approximately 100 countries, Quintiles is a member of the Fortune 500 and has been named to Fortune’s list of the “World’s Most Admired Companies.”
